<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2020-10-07" version="220">
<accession>P35568</accession>
<name>IRS1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Insulin receptor substrate 1</fullName>
<shortName>IRS-1</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary">IRS1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Diabetes" volume="42" first="1041" last="1054">
<title>Human skeletal muscle insulin receptor substrate-1. Characterization of the cDNA, gene, and chromosomal localization.</title>
<authorList>
<person name="Araki E."/>
<person name="Sun X.J."/>
<person name="Haag B.L. III"/>
<person name="Chuang L.M."/>
<person name="Zhang Y."/>
<person name="Yang-Feng T.L."/>
<person name="White M.F."/>
<person name="Kahn C.R."/>
</authorList>
<dbReference type="PubMed" id="8513971"/>
<dbReference type="DOI" id="10.2337/diab.42.7.1041"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Biochem. Biophys. Res. Commun." volume="183" first="280" last="285">
<title>Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma.</title>
<authorList>
<person name="Nishiyama M."/>
<person name="Wands J.R."/>
</authorList>
<dbReference type="PubMed" id="1311924"/>
<dbReference type="DOI" id="10.1016/0006-291x(92)91640-c"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Eye</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="196" first="767" last="772">
<title>The insulin receptor substrate (IRS-1) is a PEST protein that is susceptible to calpain degradation in vitro.</title>
<authorList>
<person name="Smith L.K."/>
<person name="Bradshaw M."/>
<person name="Croall D.E."/>
<person name="Garner C.W."/>
</authorList>
<dbReference type="PubMed" id="8240352"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.2315"/>
</citation>
<scope>TURNOVER</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="15639" last="15643">
<title>Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor.</title>
<authorList>
<person name="Craparo A."/>
<person name="O'Neill T.J."/>
<person name="Gustafson T.A."/>
</authorList>
<dbReference type="PubMed" id="7541045"/>
<dbReference type="DOI" id="10.1074/jbc.270.26.15639"/>
</citation>
<scope>INTERACTION WITH IGF1R</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="23258" last="23262">
<title>Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains.</title>
<authorList>
<person name="He W."/>
<person name="O'Neill T.J."/>
<person name="Gustafson T.A."/>
</authorList>
<dbReference type="PubMed" id="7559478"/>
<dbReference type="DOI" id="10.1074/jbc.270.40.23258"/>
</citation>
<scope>INTERACTION WITH INSR</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="Mol. Cell. Biol." volume="15" first="2500" last="2508">
<title>Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.</title>
<authorList>
<person name="Gustafson T.A."/>
<person name="He W."/>
<person name="Craparo A."/>
<person name="Schaub C.D."/>
<person name="O'Neill T.J."/>
</authorList>
<dbReference type="PubMed" id="7537849"/>
<dbReference type="DOI" id="10.1128/mcb.15.5.2500"/>
</citation>
<scope>INTERACTION WITH INSR</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="18440" last="18447">
<title>Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2.</title>
<authorList>
<person name="Horike N."/>
<person name="Takemori H."/>
<person name="Katoh Y."/>
<person name="Doi J."/>
<person name="Min L."/>
<person name="Asano T."/>
<person name="Sun X.J."/>
<person name="Yamamoto H."/>
<person name="Kasayama S."/>
<person name="Muraoka M."/>
<person name="Nonaka Y."/>
<person name="Okamoto M."/>
</authorList>
<dbReference type="PubMed" id="12624099"/>
<dbReference type="DOI" id="10.1074/jbc.m211770200"/>
</citation>
<scope>MUTAGENESIS OF SER-794</scope>
<scope>PHOSPHORYLATION AT SER-794</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="45304" last="45307">
<title>Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101).</title>
<authorList>
<person name="Li Y."/>
<person name="Soos T.J."/>
<person name="Li X."/>
<person name="Wu J."/>
<person name="Degennaro M."/>
<person name="Sun X."/>
<person name="Littman D.R."/>
<person name="Birnbaum M.J."/>
<person name="Polakiewicz R.D."/>
</authorList>
<dbReference type="PubMed" id="15364919"/>
<dbReference type="DOI" id="10.1074/jbc.c400186200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-1101</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Cell Sci." volume="117" first="3319" last="3329">
<title>ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.</title>
<authorList>
<person name="Motegi A."/>
<person name="Fujimoto J."/>
<person name="Kotani M."/>
<person name="Sakuraba H."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="15226403"/>
<dbReference type="DOI" id="10.1242/jcs.01183"/>
</citation>
<scope>PHOSPHORYLATION BY ALK</scope>
<scope>INTERACTION WITH ALK</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Clin. Invest." volume="115" first="2462" last="2471">
<title>Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans.</title>
<authorList>
<person name="Banks A.S."/>
<person name="Li J."/>
<person name="McKeag L."/>
<person name="Hribal M.L."/>
<person name="Kashiwada M."/>
<person name="Accili D."/>
<person name="Rothman P.B."/>
</authorList>
<dbReference type="PubMed" id="16127460"/>
<dbReference type="DOI" id="10.1172/jci23853"/>
</citation>
<scope>INTERACTION WITH SOCS7</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-662</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629 AND SER-636</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="859" last="869">
<title>Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase.</title>
<authorList>
<person name="Kuo A.H."/>
<person name="Stoica G.E."/>
<person name="Riegel A.T."/>
<person name="Wellstein A."/>
</authorList>
<dbReference type="PubMed" id="16878150"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209840"/>
</citation>
<scope>INTERACTION WITH ALK</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="35375" last="35382">
<title>S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2.</title>
<authorList>
<person name="Zhang J."/>
<person name="Gao Z."/>
<person name="Yin J."/>
<person name="Quon M.J."/>
<person name="Ye J."/>
</authorList>
<dbReference type="PubMed" id="18952604"/>
<dbReference type="DOI" id="10.1074/jbc.m806480200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-270; SER-307; SER-636 AND SER-1101</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Mol. Cell" volume="30" first="403" last="414">
<title>The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation.</title>
<authorList>
<person name="Xu X."/>
<person name="Sarikas A."/>
<person name="Dias-Santagata D.C."/>
<person name="Dolios G."/>
<person name="Lafontant P.J."/>
<person name="Tsai S.C."/>
<person name="Zhu W."/>
<person name="Nakajima H."/>
<person name="Nakajima H.O."/>
<person name="Field L.J."/>
<person name="Wang R."/>
<person name="Pan Z.Q."/>
</authorList>
<dbReference type="PubMed" id="18498745"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.03.009"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>PHOSPHORYLATION AT SER-307; SER-312; SER-527 AND SER-636</scope>
<scope>MUTAGENESIS OF SER-307; SER-312; SER-527; SER-636 AND SER-639</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-348</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="3449" last="3458">
<title>The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells.</title>
<authorList>
<person name="Yang X."/>
<person name="Nath A."/>
<person name="Opperman M.J."/>
<person name="Chan C."/>
</authorList>
<dbReference type="PubMed" id="20685959"/>
<dbReference type="DOI" id="10.1091/mbc.e10-06-0481"/>
</citation>
<scope>PHOSPHORYLATION AT SER-312 AND TYR-941</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="1608" last="1620">
<title>C1-Ten is a protein tyrosine phosphatase of insulin receptor substrate 1 (IRS-1), regulating IRS-1 stability and muscle atrophy.</title>
<authorList>
<person name="Koh A."/>
<person name="Lee M.N."/>
<person name="Yang Y.R."/>
<person name="Jeong H."/>
<person name="Ghim J."/>
<person name="Noh J."/>
<person name="Kim J."/>
<person name="Ryu D."/>
<person name="Park S."/>
<person name="Song P."/>
<person name="Koo S.H."/>
<person name="Leslie N.R."/>
<person name="Berggren P.O."/>
<person name="Choi J.H."/>
<person name="Suh P.G."/>
<person name="Ryu S.H."/>
</authorList>
<dbReference type="PubMed" id="23401856"/>
<dbReference type="DOI" id="10.1128/mcb.01447-12"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-612; TYR-632 AND TYR-896</scope>
<scope>MUTAGENESIS OF TYR-612 AND TYR-632</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323; THR-453; SER-527 AND SER-629</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="1996" name="Nat. Struct. Biol." volume="3" first="388" last="393">
<title>Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain.</title>
<authorList>
<person name="Zhou M.-M."/>
<person name="Huang B."/>
<person name="Olejniczak E.T."/>
<person name="Meadows R.P."/>
<person name="Shuker S.B."/>
<person name="Miyazaki M."/>
<person name="Trueb T."/>
<person name="Shoelson S.E."/>
<person name="Fesik S.W."/>
</authorList>
<dbReference type="PubMed" id="8599766"/>
<dbReference type="DOI" id="10.1038/nsb0496-388"/>
</citation>
<scope>STRUCTURE BY NMR OF 157-267</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="8378" last="8383">
<title>Crystal structure of the pleckstrin homology-phosphotyrosine binding (PH-PTB) targeting region of insulin receptor substrate 1.</title>
<authorList>
<person name="Dhe-Paganon S."/>
<person name="Ottinger E.A."/>
<person name="Nolte R.T."/>
<person name="Eck M.J."/>
<person name="Shoelson S.E."/>
</authorList>
<dbReference type="PubMed" id="10411883"/>
<dbReference type="DOI" id="10.1073/pnas.96.15.8378"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 4-267</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="1058" last="1063">
<title>Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.</title>
<authorList>
<person name="Favelyukis S."/>
<person name="Till J.H."/>
<person name="Hubbard S.R."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="11694888"/>
<dbReference type="DOI" id="10.1038/nsb721"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 889-902 IN COMPLEX WITH IGF1R</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1993" name="Lancet" volume="342" first="828" last="832">
<title>Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus.</title>
<authorList>
<person name="Almind K."/>
<person name="Bjoerbaek C."/>
<person name="Vestergaard H."/>
<person name="Hansen T."/>
<person name="Echwald S."/>
<person name="Pedersen O."/>
</authorList>
<dbReference type="PubMed" id="8104271"/>
<dbReference type="DOI" id="10.1016/0140-6736(93)92694-o"/>
</citation>
<scope>VARIANTS PRO-512 AND ARG-971</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="364" last="366">
<title>Deletion of Gly723 in the insulin receptor substrate-1 of a patient with noninsulin-dependent diabetes mellitus.</title>
<authorList>
<person name="Esposito D.L."/>
<person name="Mammarella S."/>
<person name="Ranieri A."/>
<person name="della Loggia F."/>
<person name="Capani F."/>
<person name="Consoli A."/>
<person name="Mariani-Costantini R."/>
<person name="Caramia F.G."/>
<person name="Cama A."/>
<person name="Battista P."/>
</authorList>
<dbReference type="PubMed" id="8723689"/>
<dbReference type="DOI" id="10.1002/(sici)1098-1004(1996)7:4&lt;364::aid-humu13&gt;3.0.co;2-0"/>
</citation>
<scope>VARIANT NIDDM GLY-723 DEL</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="411" last="411">
<title>Novel allele of the insulin receptor substrate-1 bearing two non-conservative amino acid substitutions in a patient with noninsulin-dependent diabetes mellitus.</title>
<authorList>
<person name="Mammarella S."/>
<person name="Creati B."/>
<person name="Esposito D.L."/>
<person name="Arcuri P."/>
<person name="della Loggia F."/>
<person name="Capani F."/>
<person name="Mariani-Costantini R."/>
<person name="Caramia F.G."/>
<person name="Battista P."/>
<person name="Cama A."/>
</authorList>
<dbReference type="PubMed" id="10206679"/>
<dbReference type="DOI" id="10.1002/(sici)1098-1004(1998)11:5&lt;411::aid-humu12&gt;3.0.co;2-#"/>
</citation>
<scope>VARIANTS NIDDM TYR-1043 AND TYR-1095</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="2004" last="2013">
<title>The Gly--&gt;Arg(972) amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells.</title>
<authorList>
<person name="Hribal M.L."/>
<person name="Federici M."/>
<person name="Porzio O."/>
<person name="Lauro D."/>
<person name="Borboni P."/>
<person name="Accili D."/>
<person name="Lauro R."/>
<person name="Sesti G."/>
</authorList>
<dbReference type="PubMed" id="10843189"/>
<dbReference type="DOI" id="10.1210/jcem.85.5.6608"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT ARG-971</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="3368" last="3371">
<title>The Arg(972) variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients.</title>
<authorList>
<person name="Marini M.A."/>
<person name="Frontoni S."/>
<person name="Mineo D."/>
<person name="Bracaglia D."/>
<person name="Cardellini M."/>
<person name="De Nicolais P."/>
<person name="Baroni A."/>
<person name="D'Alfonso R."/>
<person name="Perna M."/>
<person name="Lauro D."/>
<person name="Federici M."/>
<person name="Gambardella S."/>
<person name="Lauro R."/>
<person name="Sesti G."/>
</authorList>
<dbReference type="PubMed" id="12843189"/>
<dbReference type="DOI" id="10.1210/jc.2002-021716"/>
</citation>
<scope>ASSOCIATION OF VARIANT ARG-971 WITH NIDDM</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="5927" last="5934">
<title>Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance.</title>
<authorList>
<person name="Abate N."/>
<person name="Carulli L."/>
<person name="Cabo-Chan A. Jr."/>
<person name="Chandalia M."/>
<person name="Snell P.G."/>
<person name="Grundy S.M."/>
</authorList>
<dbReference type="PubMed" id="14671192"/>
<dbReference type="DOI" id="10.1210/jc.2003-030453"/>
</citation>
<scope>VARIANT ARG-971</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="1468" last="1475">
<title>A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling.</title>
<authorList>
<person name="Esposito D.L."/>
<person name="Li Y."/>
<person name="Vanni C."/>
<person name="Mammarella S."/>
<person name="Veschi S."/>
<person name="Della Loggia F."/>
<person name="Mariani-Costantini R."/>
<person name="Battista P."/>
<person name="Quon M.J."/>
<person name="Cama A."/>
</authorList>
<dbReference type="PubMed" id="12679424"/>
<dbReference type="DOI" id="10.1210/jc.2002-020933"/>
</citation>
<scope>VARIANT ARG-608</scope>
<scope>CHARACTERIZATION OF VARIANT ARG-608</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="Circulation" volume="109" first="399" last="405">
<title>G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells.</title>
<authorList>
<person name="Federici M."/>
<person name="Pandolfi A."/>
<person name="De Filippis E.A."/>
<person name="Pellegrini G."/>
<person name="Menghini R."/>
<person name="Lauro D."/>
<person name="Cardellini M."/>
<person name="Romano M."/>
<person name="Sesti G."/>
<person name="Lauro R."/>
<person name="Consoli A."/>
</authorList>
<dbReference type="PubMed" id="14707024"/>
<dbReference type="DOI" id="10.1161/01.cir.0000109498.77895.6f"/>
</citation>
<scope>VARIANT ARG-971</scope>
<scope>ASSOCIATION WITH ENDOTHELIAL DYSFUNCTION</scope>
<scope>CARDIOVASCULAR DISEASE</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="6441" last="6446">
<title>Human insulin receptor substrate-1 (IRS-1) polymorphism G972R causes IRS-1 to associate with the insulin receptor and inhibit receptor autophosphorylation.</title>
<authorList>
<person name="McGettrick A.J."/>
<person name="Feener E.P."/>
<person name="Kahn C.R."/>
</authorList>
<dbReference type="PubMed" id="15590636"/>
<dbReference type="DOI" id="10.1074/jbc.m412300200"/>
</citation>
<scope>VARIANT ARG-971</scope>
<scope>MOLECULAR MECHANISM OF LINKAGE TO NIDDM</scope>
</reference>
<comment type="function">
<text evidence="8 24">May mediate the control of various cellular processes by insulin. When phosphorylated by the insulin receptor binds specifically to various cellular proteins containing SH2 domains such as phosphatidylinositol 3-kinase p85 subunit or GRB2. Activates phosphatidylinositol 3-kinase when bound to the regulatory p85 subunit (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="9 10 20 23 24 29 30 31">Interacts with UBTF and PIK3CA (By similarity). Interacts (via phosphorylated YXXM motifs) with PIK3R1 (By similarity). Interacts with ROCK1 and FER (By similarity). Interacts (via PH domain) with PHIP (By similarity). Interacts with GRB2 (By similarity). Interacts with SOCS7 (PubMed:16127460). Interacts (via IRS-type PTB domain) with IGF1R and INSR (via the tyrosine-phosphorylated NPXY motif) (PubMed:7541045, PubMed:7559478, PubMed:7537849). Interacts with ALK (PubMed:15226403, PubMed:16878150). Interacts with EIF2AK2/PKR (By similarity). Interacts with GKAP1 (By similarity). Interacts with DGKZ in the absence of insulin; insulin stimulation decreases this interaction (By similarity). Found in a ternary complex with DGKZ and PIP5K1A in the absence of insulin stimulation (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-702336">
<id>O75815</id>
<label>BCAR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-475899">
<id>P06213</id>
<label>INSR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-81531">
<id>P11940</id>
<label>PABPC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-2116585">
<id>P42336</id>
<label>PIK3CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>20</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-9090282">
<id>P27986-2</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-297779">
<id>Q06124</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-2548993">
<id>P03495</id>
<label>NS</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-517592">
<id>P35568</id>
</interactant>
<interactant intactId="EBI-617698">
<id>P03070</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="PTM">
<text evidence="9 10 21 25 26 27 28">Serine phosphorylation of IRS1 is a mechanism for insulin resistance. Ser-312 phosphorylation inhibits insulin action through disruption of IRS1 interaction with the insulin receptor (By similarity). Phosphorylation of Tyr-896 is required for GRB2-binding (By similarity). Phosphorylated by ALK. Phosphorylated at Ser-270, Ser-307, Ser-636 and Ser-1101 by RPS6KB1; phosphorylation induces accelerated degradation of IRS1 (PubMed:18952604). Phosphorylated on tyrosine residues in response to insulin (PubMed:23401856). In skeletal muscles, dephosphorylated on Tyr-612 by TNS2 under anabolic conditions; dephosphorylation results in the proteasomal degradation of IRS1 (PubMed:23401856).</text>
</comment>
<comment type="PTM">
<text evidence="25">Ubiquitinated by the Cul7-RING(FBXW8) complex in a mTOR-dependent manner, leading to its degradation: the Cul7-RING(FBXW8) complex recognizes and binds IRS1 previously phosphorylated by S6 kinase (RPS6KB1 or RPS6KB2).</text>
</comment>
<comment type="polymorphism">
<text>The Arg-971 polymorphism impairs the ability of insulin to stimulate glucose transport, glucose transporter translocation, and glycogen synthesis by affecting the PI3K/AKT1/GSK3 signaling pathway. The polymorphism at Arg-971 may contribute to the in vivo insulin resistance observed in carriers of this variant. Arg-971 could contribute to the risk for atherosclerotic cardiovascular diseases associated with non-insulin-dependent diabetes mellitus (NIDDM) by producing a cluster of insulin resistance-related metabolic abnormalities. In insulin-stimulated human endothelial cells from carriers of the Arg-971 polymorphism, genetic impairment of the IRS1/PI3K/PDPK1/AKT1 insulin signaling cascade results in impaired insulin-stimulated nitric oxide (NO) release and suggested that this may be a mechanism through which the Arg-971 polymorphism contributes to the genetic predisposition to develop endothelial dysfunction and cardiovascular disease. The Arg-971 polymorphism not only reduces phosphorylation of the substrate but allows IRS1 to act as an inhibitor of PI3K, producing global insulin resistance.</text>
</comment>
<comment type="disease" evidence="13 17 33">
<disease id="DI-02060">
<name>Diabetes mellitus, non-insulin-dependent</name>
<acronym>NIDDM</acronym>
<description>A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.</description>
<dbReference type="MIM" id="125853"/>
</disease>
<text>The gene represented in this entry may be involved in disease pathogenesis.</text>
</comment>
<dbReference type="EMBL" id="S85963">
<property type="protein sequence ID" value="AAB21608.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S62539">
<property type="protein sequence ID" value="AAB27175.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC053895">
<property type="protein sequence ID" value="AAH53895.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2463.1"/>
<dbReference type="PIR" id="I53160">
<property type="entry name" value="JS0670"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005535.1">
<property type="nucleotide sequence ID" value="NM_005544.2"/>
</dbReference>
<dbReference type="PDB" id="1IRS">
<property type="method" value="NMR"/>
<property type="chains" value="A=157-267"/>
</dbReference>
<dbReference type="PDB" id="1K3A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="B=891-902"/>
</dbReference>
<dbReference type="PDB" id="1QQG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=4-267"/>
</dbReference>
<dbReference type="PDB" id="2Z8C">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="B=731-736"/>
</dbReference>
<dbReference type="PDB" id="5U1M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=161-265"/>
</dbReference>
<dbReference type="PDB" id="6BNT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="B=607-620"/>
</dbReference>
<dbReference type="PDBsum" id="1IRS"/>
<dbReference type="PDBsum" id="1K3A"/>
<dbReference type="PDBsum" id="1QQG"/>
<dbReference type="PDBsum" id="2Z8C"/>
<dbReference type="PDBsum" id="5U1M"/>
<dbReference type="PDBsum" id="6BNT"/>
<dbReference type="BMRB" id="P35568"/>
<dbReference type="SMR" id="P35568"/>
<dbReference type="BioGRID" id="109874">
<property type="interactions" value="95"/>
</dbReference>
<dbReference type="CORUM" id="P35568"/>
<dbReference type="DIP" id="DIP-523N"/>
<dbReference type="ELM" id="P35568"/>
<dbReference type="IntAct" id="P35568">
<property type="interactions" value="33"/>
</dbReference>
<dbReference type="MINT" id="P35568"/>
<dbReference type="STRING" id="9606.ENSP00000304895"/>
<dbReference type="DrugBank" id="DB08513">
<property type="generic name" value="[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID"/>
</dbReference>
<dbReference type="iPTMnet" id="P35568"/>
<dbReference type="PhosphoSitePlus" id="P35568"/>
<dbReference type="BioMuta" id="IRS1"/>
<dbReference type="DMDM" id="547738"/>
<dbReference type="EPD" id="P35568"/>
<dbReference type="jPOST" id="P35568"/>
<dbReference type="MassIVE" id="P35568"/>
<dbReference type="MaxQB" id="P35568"/>
<dbReference type="PaxDb" id="P35568"/>
<dbReference type="PeptideAtlas" id="P35568"/>
<dbReference type="PRIDE" id="P35568"/>
<dbReference type="ProteomicsDB" id="55088"/>
<dbReference type="Antibodypedia" id="3935">
<property type="antibodies" value="2465 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3667"/>
<dbReference type="Ensembl" id="ENST00000305123">
<property type="protein sequence ID" value="ENSP00000304895"/>
<property type="gene ID" value="ENSG00000169047"/>
</dbReference>
<dbReference type="GeneID" id="3667"/>
<dbReference type="KEGG" id="hsa:3667"/>
<dbReference type="UCSC" id="uc002voh.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3667"/>
<dbReference type="DisGeNET" id="3667"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000169047.5"/>
<dbReference type="GeneCards" id="IRS1"/>
<dbReference type="HGNC" id="HGNC:6125">
<property type="gene designation" value="IRS1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000169047">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="IRS1"/>
<dbReference type="MIM" id="125853">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="147545">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P35568"/>
<dbReference type="OpenTargets" id="ENSG00000169047"/>
<dbReference type="PharmGKB" id="PA203"/>
<dbReference type="eggNOG" id="ENOG502QUNU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000161579"/>
<dbReference type="HOGENOM" id="CLU_004902_2_0_1"/>
<dbReference type="InParanoid" id="P35568"/>
<dbReference type="KO" id="K16172"/>
<dbReference type="OMA" id="YGKLWTN"/>
<dbReference type="OrthoDB" id="298675at2759"/>
<dbReference type="PhylomeDB" id="P35568"/>
<dbReference type="TreeFam" id="TF325994"/>
<dbReference type="PathwayCommons" id="P35568"/>
<dbReference type="Reactome" id="R-HSA-109704">
<property type="pathway name" value="PI3K Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112399">
<property type="pathway name" value="IRS-mediated signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112412">
<property type="pathway name" value="SOS-mediated signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1266695">
<property type="pathway name" value="Interleukin-7 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198203">
<property type="pathway name" value="PI3K/AKT activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2428928">
<property type="pathway name" value="IRS-related events triggered by IGF1R"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2586552">
<property type="pathway name" value="Signaling by Leptin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-74713">
<property type="pathway name" value="IRS activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-74749">
<property type="pathway name" value="Signal attenuation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9603381">
<property type="pathway name" value="Activated NTRK3 signals through PI3K"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-982772">
<property type="pathway name" value="Growth hormone receptor signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P35568"/>
<dbReference type="SIGNOR" id="P35568"/>
<dbReference type="BioGRID-ORCS" id="3667">
<property type="hits" value="22 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IRS1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P35568"/>
<dbReference type="GeneWiki" id="IRS1"/>
<dbReference type="GenomeRNAi" id="3667"/>
<dbReference type="Pharos" id="P35568">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P35568"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="P35568">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000169047">
<property type="expression patterns" value="Expressed in endometrium and 248 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P35568">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P35568">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005901">
<property type="term" value="C:caveola"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005899">
<property type="term" value="C:insulin receptor complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005158">
<property type="term" value="F:insulin receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005159">
<property type="term" value="F:insulin-like growth factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043548">
<property type="term" value="F:phosphatidylinositol 3-kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005080">
<property type="term" value="F:protein kinase C binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042169">
<property type="term" value="F:SH2 domain binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030159">
<property type="term" value="F:signaling receptor complex adaptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005068">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase adaptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071398">
<property type="term" value="P:cellular response to fatty acid"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008286">
<property type="term" value="P:insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048009">
<property type="term" value="P:insulin-like growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038111">
<property type="term" value="P:interleukin-7-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046627">
<property type="term" value="P:negative regulation of insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046676">
<property type="term" value="P:negative regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032000">
<property type="term" value="P:positive regulation of fatty acid beta-oxidation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046326">
<property type="term" value="P:positive regulation of glucose import"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010907">
<property type="term" value="P:positive regulation of glucose metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045725">
<property type="term" value="P:positive regulation of glycogen biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046628">
<property type="term" value="P:positive regulation of insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032868">
<property type="term" value="P:response to insulin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="CDD" id="cd01204">
<property type="entry name" value="PTB_IRS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="IDEAL" id="IID00657"/>
<dbReference type="InterPro" id="IPR039011">
<property type="entry name" value="IRS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002404">
<property type="entry name" value="IRS_PTB"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001849">
<property type="entry name" value="PH_domain"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10614">
<property type="entry name" value="PTHR10614"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02174">
<property type="entry name" value="IRS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00169">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00628">
<property type="entry name" value="INSULINRSI"/>
</dbReference>
<dbReference type="SMART" id="SM00233">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00310">
<property type="entry name" value="PTBI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51064">
<property type="entry name" value="IRS_PTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50003">
<property type="entry name" value="PH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0219">Diabetes mellitus</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0807">Transducer</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Insulin receptor substrate 1" id="PRO_0000084236">
<location>
<begin position="1"/>
<end position="1242"/>
</location>
</feature>
<feature type="domain" description="PH" evidence="11">
<location>
<begin position="12"/>
<end position="115"/>
</location>
</feature>
<feature type="domain" description="IRS-type PTB" evidence="12">
<location>
<begin position="160"/>
<end position="264"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with PHIP" evidence="8">
<location>
<begin position="3"/>
<end position="137"/>
</location>
</feature>
<feature type="region of interest" description="GRB2-binding" evidence="8">
<location>
<begin position="896"/>
<end position="898"/>
</location>
</feature>
<feature type="short sequence motif" description="YXXM motif 1">
<location>
<begin position="465"/>
<end position="468"/>
</location>
</feature>
<feature type="short sequence motif" description="YXXM motif 2">
<location>
<begin position="551"/>
<end position="554"/>
</location>
</feature>
<feature type="short sequence motif" description="YXXM motif 3">
<location>
<begin position="612"/>
<end position="615"/>
</location>
</feature>
<feature type="short sequence motif" description="YXXM motif 4">
<location>
<begin position="632"/>
<end position="635"/>
</location>
</feature>
<feature type="short sequence motif" description="YXXM motif 5">
<location>
<begin position="662"/>
<end position="665"/>
</location>
</feature>
<feature type="short sequence motif" description="YXXM motif 6">
<location>
<begin position="732"/>
<end position="735"/>
</location>
</feature>
<feature type="short sequence motif" description="YXXM motif 7">
<location>
<begin position="941"/>
<end position="944"/>
</location>
</feature>
<feature type="short sequence motif" description="YXXM motif 8">
<location>
<begin position="989"/>
<end position="992"/>
</location>
</feature>
<feature type="short sequence motif" description="YXXM motif 9">
<location>
<begin position="1012"/>
<end position="1015"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="128"/>
<end position="134"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="268"/>
<end position="444"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="680"/>
<end position="686"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="807"/>
<end position="815"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="877"/>
<end position="882"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="1192"/>
<end position="1210"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="10">
<location>
<position position="99"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RPS6KB1" evidence="26">
<location>
<position position="270"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RPS6KB1" evidence="25 26">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKB, MAPK8 and RPS6KB1" evidence="25 27">
<location>
<position position="312"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="323"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="330"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="345"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="348"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="419"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="446"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="453"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by INSR" evidence="10">
<location>
<position position="465"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RPS6KB1" evidence="7 25">
<location>
<position position="527"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by INSR" evidence="28">
<location>
<position position="612"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7">
<location>
<position position="629"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by INSR" evidence="28">
<location>
<position position="632"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RPS6KB1" evidence="5 25 26">
<location>
<position position="636"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4">
<location>
<position position="662"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AMPK and SIK2" evidence="15">
<location>
<position position="794"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="892"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by INSR" evidence="28">
<location>
<position position="896"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by INSR" evidence="27">
<location>
<position position="941"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by INSR" evidence="10">
<location>
<position position="989"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1100"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RPS6KB1 and PKC/PRKCQ" evidence="21 26">
<location>
<position position="1101"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by INSR" evidence="10">
<location>
<position position="1179"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by INSR" evidence="10">
<location>
<position position="1229"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801108." id="VAR_014853">
<original>P</original>
<variation>R</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801118." id="VAR_014854">
<original>M</original>
<variation>T</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801276." id="VAR_005299" evidence="32">
<original>A</original>
<variation>P</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="sequence variant" description="May contribute to insulin resistance by impairing metabolic signaling through PI3K-dependent pathways; dbSNP:rs104893642." id="VAR_025320" evidence="16">
<original>T</original>
<variation>R</variation>
<location>
<position position="608"/>
</location>
</feature>
<feature type="sequence variant" description="In NIDDM." id="VAR_005301" evidence="33">
<location>
<position position="723"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801120." id="VAR_014855">
<original>S</original>
<variation>F</variation>
<location>
<position position="809"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801277." id="VAR_014856">
<original>S</original>
<variation>G</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1801278." id="VAR_005300" evidence="14 18 19 22 32">
<original>G</original>
<variation>R</variation>
<location>
<position position="971"/>
</location>
</feature>
<feature type="sequence variant" description="In NIDDM." id="VAR_005302" evidence="13">
<original>S</original>
<variation>Y</variation>
<location>
<position position="1043"/>
</location>
</feature>
<feature type="sequence variant" description="In NIDDM." id="VAR_005303" evidence="13">
<original>C</original>
<variation>Y</variation>
<location>
<position position="1095"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3731594." id="VAR_021837">
<original>D</original>
<variation>N</variation>
<location>
<position position="1137"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-312; A-527; A-636 and A-639." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-307; A-527; A-636 and A-639." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-307; A-312; A-636 and A-639." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="527"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces IRS1 degradation." evidence="28">
<original>Y</original>
<variation>F</variation>
<location>
<position position="612"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect IRS1 stability." evidence="28">
<original>Y</original>
<variation>F</variation>
<location>
<position position="632"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-307; A-312; A-527 and A-639." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="636"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired degradation by the Cul7-RING(FBXW8) complex; when associated with A-307; A-312; A-527 and A-636." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="639"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by SIK2." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="794"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB21608." ref="2" evidence="34">
<original>G</original>
<variation>GG</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB21608." ref="2" evidence="34">
<original>S</original>
<variation>R</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB21608." ref="2" evidence="34">
<original>P</original>
<variation>R</variation>
<location>
<position position="384"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="13"/>
<end position="20"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="22"/>
<end position="24"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="27"/>
<end position="33"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="49"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="50"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="61"/>
<end position="65"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="66"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="69"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="81"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="92"/>
<end position="96"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="100"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="162"/>
<end position="172"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="173"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="181"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="189"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="203"/>
<end position="207"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="208"/>
<end position="210"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="211"/>
<end position="217"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="220"/>
<end position="225"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="233"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="243"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="897"/>
<end position="901"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1K3A"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QQG"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5U1M"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P35569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P35570"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00145"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00389"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10206679"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10843189"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12624099"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12679424"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12843189"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14671192"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14707024"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15226403"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15364919"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15590636"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16127460"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16878150"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18498745"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18952604"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20685959"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23401856"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7537849"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7541045"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7559478"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8104271"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8723689"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<sequence length="1242" mass="131591" checksum="3C0EFD9E32B3E64A" modified="1994-06-01" version="1">MASPPESDGFSDVRKVGYLRKPKSMHKRFFVLRAASEAGGPARLEYYENEKKWRHKSSAPKRSIPLESCFNINKRADSKNKHLVALYTRDEHFAIAADSEAEQDSWYQALLQLHNRAKGHHDGAAALGAGGGGGSCSGSSGLGEAGEDLSYGDVPPGPAFKEVWQVILKPKGLGQTKNLIGIYRLCLTSKTISFVKLNSEAAAVVLQLMNIRRCGHSENFFFIEVGRSAVTGPGEFWMQVDDSVVAQNMHETILEAMRAMSDEFRPRSKSQSSSNCSNPISVPLRRHHLNNPPPSQVGLTRRSRTESITATSPASMVGGKPGSFRVRASSDGEGTMSRPASVDGSPVSPSTNRTHAHRHRGSARLHPPLNHSRSIPMPASRCSPSATSPVSLSSSSTSGHGSTSDCLFPRRSSASVSGSPSDGGFISSDEYGSSPCDFRSSFRSVTPDSLGHTPPARGEEELSNYICMGGKGPSTLTAPNGHYILSRGGNGHRCTPGTGLGTSPALAGDEAASAADLDNRFRKRTHSAGTSPTITHQKTPSQSSVASIEEYTEMMPAYPPGGGSGGRLPGHRHSAFVPTRSYPEEGLEMHPLERRGGHHRPDSSTLHTDDGYMPMSPGVAPVPSGRKGSGDYMPMSPKSVSAPQQIINPIRRHPQRVDPNGYMMMSPSGGCSPDIGGGPSSSSSSSNAVPSGTSYGKLWTNGVGGHHSHVLPHPKPPVESSGGKLLPCTGDYMNMSPVGDSNTSSPSDCYYGPEDPQHKPVLSYYSLPRSFKHTQRPGEPEEGARHQHLRLSTSSGRLLYAATADDSSSSTSSDSLGGGYCGARLEPSLPHPHHQVLQPHLPRKVDTAAQTNSRLARPTRLSLGDPKASTLPRAREQQQQQQPLLHPPEPKSPGEYVNIEFGSDQSGYLSGPVAFHSSPSVRCPSQLQPAPREEETGTEEYMKMDLGPGRRAAWQESTGVEMGRLGPAPPGAASICRPTRAVPSSRGDYMTMQMSCPRQSYVDTSPAAPVSYADMRTGIAAEEVSLPRATMAAASSSSAASASPTGPQGAAELAAHSSLLGGPQGPGGMSAFTRVNLSPNRNQSAKVIRADPQGCRRRHSSETFSSTPSATRVGNTVPFGAGAAVGGGGGSSSSSEDVKRHSSASFENVWLRPGELGGAPKEPAKLCGAAGGLENGLNYIDLDLVKDFKQCPQECTPEPQPPPPPPPHQPLGSGESSSTRRSSEDLSAYASISFQKQPEDRQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

